Bausch + Lomb (NYSE:BLCO) Price Target Raised to $19.00

by · The Markets Daily

Bausch + Lomb (NYSE:BLCO – Free Report) had its price target increased by Wells Fargo & Company from $18.00 to $19.00 in a research report released on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other brokerages also recently commented on BLCO. UBS Group began coverage on shares of Bausch + Lomb in a research report on Thursday, July 30th. They issued a “buy” rating and a $21.00 price objective for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Bausch + Lomb in a report on Tuesday, September 15th. Leerink Partners assumed coverage on shares of Bausch + Lomb in a research note on Wednesday, September 9th. They issued an “outperform” rating and a $24.00 target price for the company. Barclays upgraded shares of Bausch + Lomb to a “strong-buy” rating in a research note on Wednesday, October 7th. Finally, Weiss Ratings upgraded Bausch + Lomb from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Bausch + Lomb presently has a consensus rating of “Hold” and a consensus price target of $20.75.

View Our Latest Analysis on Bausch + Lomb

Bausch + Lomb Price Performance

NYSE:BLCO opened at $19.99 on Thursday. Bausch + Lomb has a 1-year low of $14.44 and a 1-year high of $21.36. The company has a current ratio of 1.56, a quick ratio of 1.02 and a debt-to-equity ratio of 0.78. The firm has a fifty day simple moving average of $17.35 and a 200 day simple moving average of $16.69. The stock has a market capitalization of $7.14 billion, a PE ratio of -64.48, a P/E/G ratio of 0.59 and a beta of 0.56.

Bausch + Lomb (NYSE:BLCO – Get Free Report) last issued its earnings results on Wednesday, October 28th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.13. Bausch + Lomb had a negative net margin of 2.05% and a positive return on equity of 5.01%. The business had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period in the previous year, the company earned $0.18 earnings per share. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, research analysts expect that Bausch + Lomb will post 0.94 EPS for the current fiscal year.

Insider Buying and Selling at Bausch + Lomb

In other Bausch + Lomb news, CAO Frederick Munsch sold 52,900 shares of Bausch + Lomb stock in a transaction on Monday, August 10th. The shares were sold at an average price of $16.78, for a total transaction of $887,662.00. Following the completion of the transaction, the chief accounting officer directly owned 45,831 shares of the company’s stock, valued at $769,044.18. The trade was a 53.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Eschenbach Andrew C. Von sold 6,059 shares of Bausch + Lomb stock in a transaction on Friday, August 7th. The stock was sold at an average price of $16.58, for a total transaction of $100,458.22. Following the transaction, the director directly owned 63,733 shares of the company’s stock, valued at approximately $1,056,693.14. This trade represents a 8.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 71,459 shares of company stock valued at $1,194,370 in the last ninety days. Insiders own 1.45% of the company’s stock.

Institutional Trading of Bausch + Lomb

A number of hedge funds have recently modified their holdings of BLCO. Whitebox Advisors LLC raised its holdings in Bausch + Lomb by 15.8% in the 1st quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company’s stock valued at $17,519,000 after acquiring an additional 150,641 shares during the period. Beach Point Capital Management LP acquired a new stake in Bausch + Lomb during the third quarter worth approximately $5,882,000. Sei Investments Co. lifted its position in Bausch + Lomb by 100.0% during the first quarter. Sei Investments Co. now owns 139,266 shares of the company’s stock worth $2,214,000 after acquiring an additional 69,633 shares during the last quarter. Engineers Gate Manager LP bought a new stake in shares of Bausch + Lomb during the second quarter worth approximately $1,479,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Bausch + Lomb by 13.2% during the first quarter. Dimensional Fund Advisors LP now owns 85,779 shares of the company’s stock worth $1,362,000 after acquiring an additional 9,971 shares during the period. Institutional investors and hedge funds own 11.07% of the company’s stock.

Bausch + Lomb News Roundup

Here are the key news stories impacting Bausch + Lomb this week:

  • Positive Sentiment: Strong quarterly results: Bausch + Lomb reported adjusted earnings of $0.34 per share, well above the $0.21 consensus estimate, while revenue reached approximately $1.38 billion versus expectations of $1.37 billion. Revenue increased 7.3% year over year. Bausch + Lomb Q3 2026 Earnings
  • Positive Sentiment: Higher 2026 guidance: Management raised its forecast to $5.450 billion-$5.550 billion in revenue and $1.090 billion-$1.140 billion in adjusted EBITDA, citing continued momentum from its Vision ’27 strategy. The improved outlook supports investor confidence in growth and profitability. Bausch + Lomb Raises 2026 Guidance
  • Positive Sentiment: Analysts raised targets: RBC lifted its price target from $21 to $23 and maintained an “outperform” rating. JPMorgan raised its target from $16 to $22, although it retained a “neutral” rating. The revisions indicate that analysts see improved earnings potential following the results. RBC Raises BLCO Price Target
  • Neutral Sentiment: Deutsche Bank raised its target from $16 to $20 but kept a “hold” rating, while Wells Fargo increased its target from $18 to $19 and maintained an “equal weight” rating. These calls reflect more cautious views after the stock’s recent advance. Deutsche Bank Adjusts BLCO Price Target

About Bausch + Lomb

(Get Free Report)

Bausch + Lomb Corporation (NYSE: BLCO) is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.

See Also